Neurotrophin-3 and Neurotrophin-4
Neurotrophin-4 (NT-4), also known as neurotrophin-5 (NT-5), is a protein that in humans is encoded by the NTF4 gene. It is a neurotrophic factor that signals predominantly through the TrkB receptor tyrosine kinase. NT-4 was first discovered and isolated from xenopus and viper in the year 1991 by Finn Hallbook et.al
- GRCh38: Ensembl release 89: ENSG00000225950 – Ensembl, May 2017
- GRCm38: Ensembl release 89: ENSMUSG00000074121 – Ensembl, May 2017
- “Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- “Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- Ibáñez CF, Ernfors P, Timmusk T, Ip NY, Arenas E, Yancopoulos GD, Persson H (April 1993). “Neurotrophin-4 is a target-derived neurotrophic factor for neurons of the trigeminal ganglion”. Development. 117 (4): 1345–1353. doi:10.1242/dev.117.4.1345. PMID 8404536.
- “Entrez Gene: neurotrophin 4”.
- Klein R, Lamballe F, Bryant S, Barbacid M (May 1992). “The trkB tyrosine protein kinase is a receptor for neurotrophin-4”. Neuron. 8 (5): 947–956. doi:10.1016/0896-6273(92)90209-v. PMID 1375038. S2CID 9772551.
- Ip NY, Stitt TN, Tapley P, Klein R, Glass DJ, Fandl J, et al. (February 1993). “Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells”. Neuron. 10 (2): 137–149. doi:10.1016/0896-6273(93)90306-c. PMID 7679912. S2CID 46072027.
- Hallböök F, Ibáñez CF, Persson H (May 1991). “Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary”. Neuron. 6 (5): 845–858. doi:10.1016/0896-6273(91)90180-8. PMID 2025430. S2CID 17772282.
Neurotrophin-3 is a protein that in humans is encoded by the NTF3 gene. The protein encoded by this gene, NT-3, is a neurotrophic factor in the NGF (Nerve Growth Factor) family of neurotrophins. It is a protein growth factor which has activity on certain neurons of the peripheral and central nervous system; it helps to support the survival and differentiation of existing neurons, and encourages the growth and differentiation of new neurons and synapses. NT-3 was the third neurotrophic factor to be characterized, after nerve growth factor (NGF) and BDNF (Brain Derived Neurotrophic Factor).
- Maisonpierre PC, Le Beau MM, Espinosa R III, Ip NY, Belluscio L, de la Monte SM, Squinto S, Furth ME, Yancopoulos GD (Oct 1991). “Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations”. Genomics. 10 (3): 558–68. doi:10.1016/0888-7543(91)90436-I. PMID 1889806.
- “Entrez Gene: NTF3 neurotrophin 3”.
- Maisonpierre P, Belluscio L, Squinto S, Ip N, Furth M, Lindsay R, Yancopoulos G (1990). “Neurotrophin-3: a neurotrophic factor related to NGF and BDNF”. Science. 247 (4949 Pt 1): 1446–51. Bibcode:1990Sci…247.1446M. doi:10.1126/science.2321006. PMID 2321006. S2CID 37763746.
Function
Although the vast majority of neurons in the mammalian brain are formed prenatally, parts of the adult brain retain the ability to grow new neurons from neural stem cells; a process known as neurogenesis. Neurotrophins are chemicals that help to stimulate and control neurogenesis.
NT-3 is unique in the number of neurons it can potentially stimulate, given its ability to activate two of the receptor tyrosine kinase neurotrophin receptors (TrkC and TrkB).
- Glass DJ, Nye SH, Hantzopoulos P, Macchi MJ, Squinto SP, Goldfarb M, Yancopoulos GD (July 1991). “TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor”. Cell. 66 (2): 405–413. doi:10.1016/0092-8674(91)90629-d. PMID 1649703. S2CID 43626580.
- Ip NY, Stitt TN, Tapley P, Klein R, Glass DJ, Fandl J, Greene LA, Barbacid M, Yancopoulos GD (Feb 1993). “Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells”. Neuron. 10 (2): 137–149. doi:10.1016/0896-6273(93)90306-c. PMID 7679912. S2CID 46072027.
Mice born without the ability to make NT-3 have loss of proprioceptive and subsets of mechanoreceptive sensory neurons.
- Tessarollo L, Vogel K, Palko M, Reid S, Parada L (1994). “Targeted mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons”. Proc Natl Acad Sci USA. 91 (25): 11844–8. Bibcode:1994PNAS…9111844T. doi:10.1073/pnas.91.25.11844. PMC 45332. PMID 7991545.
- Klein R, Silos-Santiago I, Smeyne R, Lira S, Brambilla R, Bryant S, Zhang L, Snider W, Barbacid M (1994). “Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements”. Nature. 368 (6468): 249–51. Bibcode:1994Natur.368..249K. doi:10.1038/368249a0. PMID 8145824. S2CID 4328770.
Mechanism of action
NT-3 binds three receptors on the surface of cells which are capable of responding to this growth factor:
- TrkC (pronounced “Track C”), is apparently the “physiologic” receptor, in that it binds with greatest affinity to NT-3.
- Lamballe F, Klein R, Barbacid M (1991). “trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3“. Cell. 66 (5): 967–79. doi:10.1016/0092-8674(91)90442-2. PMID 1653651. S2CID 23448391.
- Tessarollo L, Tsoulfas P, Martin-Zanca D, Gilbert D, Jenkins N, Copeland N, Parada L (1993). “trkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues“. Development. 118 (2): 463–75. doi:10.1242/dev.118.2.463. PMID 8223273.
- However, NT-3 is capable of binding and signaling through a TrkC-related receptors called TrkB.
- Glass DJ, Nye SH, Hantzopoulos P, Macchi MJ, Squinto SP, Goldfarb M, Yancopoulos GD (July 1991). “TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor“. Cell. 66 (2): 405–413. doi:10.1016/0092-8674(91)90629-d. PMID 1649703. S2CID 43626580.
- Finally, NT-3 also binds a second-receptor type besides Trk receptors, called the LNGFR (for “low affinity nerve growth factor receptor).
High affinity receptors
TrkC is a receptor tyrosine kinase (meaning it mediates its actions by causing the addition of phosphate molecules on certain tyrosines in the cell, activating cellular signaling).
As mentioned above, there are other related Trk receptors, TrkA and TrkB. Also as mentioned, there are other neurotrophic factors structurally related to NT-3:
- NGF (for “Nerve Growth Factor”)
- BDNF (for “Brain Derived Neurotrophic Factor”)
- NT-4 (for “Neurotrophin-4”)
While TrkB mediates the effects of BDNF, NT-4, and NT-3, TrkA binds and is activated by NGF, and TrkC binds and is activated only by NT-3.
Low affinity receptors[edit]
The other NT-3 receptor, the LNGFR, plays a somewhat less clear role. Some researchers have shown the LNGFR binds and serves as a “sink” for neurotrophins.
The crystal structure of NT-3 shows that NT-3 forms a central homodimer around which two glycosylated p75 LNGFR molecules bind symmetrically. The symmetrical binding takes place along the NT-3 interfaces, resulting in a 2:2 ligand-receptor cluster in the center.
- Gong Y, Cao P, Yu HJ, Jiang T (August 2008). “Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex”. Nature. 454 (7205): 789–93. Bibcode:2008Natur.454..789G. doi:10.1038/nature07089. PMID 18596692. S2CID 4333271.
Cells which express both the LNGFR and the Trk receptors might therefore have a greater activity – since they have a higher “microconcentration” of the neurotrophin.
It has also been shown, however, that the LNGFR may signal a cell to die via apoptosis – so therefore cells expressing the LNGFR in the absence of Trk receptors may die rather than live in the presence of a neurotrophin.
See also
References
- GRCh38: Ensembl release 89: ENSG00000225950 – Ensembl, May 2017
- GRCm38: Ensembl release 89: ENSMUSG00000074121 – Ensembl, May 2017
- “Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- “Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- Ibáñez CF, Ernfors P, Timmusk T, Ip NY, Arenas E, Yancopoulos GD, Persson H (April 1993). “Neurotrophin-4 is a target-derived neurotrophic factor for neurons of the trigeminal ganglion”. Development. 117 (4): 1345–1353. doi:10.1242/dev.117.4.1345. PMID 8404536.
- “Entrez Gene: neurotrophin 4”.
- Klein R, Lamballe F, Bryant S, Barbacid M (May 1992). “The trkB tyrosine protein kinase is a receptor for neurotrophin-4”. Neuron. 8 (5): 947–956. doi:10.1016/0896-6273(92)90209-v. PMID 1375038. S2CID 9772551.
- Ip NY, Stitt TN, Tapley P, Klein R, Glass DJ, Fandl J, et al. (February 1993). “Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells”. Neuron. 10 (2): 137–149. doi:10.1016/0896-6273(93)90306-c. PMID 7679912. S2CID 46072027.
- Hallböök F, Ibáñez CF, Persson H (May 1991). “Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary”. Neuron. 6 (5): 845–858. doi:10.1016/0896-6273(91)90180-8. PMID 2025430. S2CID 17772282.
- GRCh38: Ensembl release 89: ENSG00000185652 – Ensembl, May 2017
- GRCm38: Ensembl release 89: ENSMUSG00000049107 – Ensembl, May 2017
- “Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- “Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- Maisonpierre PC, Le Beau MM, Espinosa R III, Ip NY, Belluscio L, de la Monte SM, Squinto S, Furth ME, Yancopoulos GD (Oct 1991). “Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations”. Genomics. 10 (3): 558–68. doi:10.1016/0888-7543(91)90436-I. PMID 1889806.
- “Entrez Gene: NTF3 neurotrophin 3”.
- Maisonpierre P, Belluscio L, Squinto S, Ip N, Furth M, Lindsay R, Yancopoulos G (1990). “Neurotrophin-3: a neurotrophic factor related to NGF and BDNF”. Science. 247 (4949 Pt 1): 1446–51. Bibcode:1990Sci…247.1446M. doi:10.1126/science.2321006. PMID 2321006. S2CID 37763746.
- Glass DJ, Nye SH, Hantzopoulos P, Macchi MJ, Squinto SP, Goldfarb M, Yancopoulos GD (July 1991). “TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor”. Cell. 66 (2): 405–413. doi:10.1016/0092-8674(91)90629-d. PMID 1649703. S2CID 43626580.
- Ip NY, Stitt TN, Tapley P, Klein R, Glass DJ, Fandl J, Greene LA, Barbacid M, Yancopoulos GD (Feb 1993). “Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells”. Neuron. 10 (2): 137–149. doi:10.1016/0896-6273(93)90306-c. PMID 7679912. S2CID 46072027.
- Tessarollo L, Vogel K, Palko M, Reid S, Parada L (1994). “Targeted mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons”. Proc Natl Acad Sci USA. 91 (25): 11844–8. Bibcode:1994PNAS…9111844T. doi:10.1073/pnas.91.25.11844. PMC 45332. PMID 7991545.
- Klein R, Silos-Santiago I, Smeyne R, Lira S, Brambilla R, Bryant S, Zhang L, Snider W, Barbacid M (1994). “Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements”. Nature. 368 (6468): 249–51. Bibcode:1994Natur.368..249K. doi:10.1038/368249a0. PMID 8145824. S2CID 4328770.
- Lamballe F, Klein R, Barbacid M (1991). “trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3”. Cell. 66 (5): 967–79. doi:10.1016/0092-8674(91)90442-2. PMID 1653651. S2CID 23448391.
- Tessarollo L, Tsoulfas P, Martin-Zanca D, Gilbert D, Jenkins N, Copeland N, Parada L (1993). “trkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues”. Development. 118 (2): 463–75. doi:10.1242/dev.118.2.463. PMID 8223273.
- Glass DJ, Nye SH, Hantzopoulos P, Macchi MJ, Squinto SP, Goldfarb M, Yancopoulos GD (July 1991). “TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor”. Cell. 66 (2): 405–413. doi:10.1016/0092-8674(91)90629-d. PMID 1649703. S2CID 43626580.
- Gong Y, Cao P, Yu HJ, Jiang T (August 2008). “Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex”. Nature. 454 (7205): 789–93. Bibcode:2008Natur.454..789G. doi:10.1038/nature07089. PMID 18596692. S2CID 4333271.
Further reading (Neurotrophin-3)
- Kalcheim C, Carmeli C, Rosenthal A (1992). “Neurotrophin 3 is a mitogen for cultured neural crest cells”. Proc. Natl. Acad. Sci. U.S.A. 89 (5): 1661–5. Bibcode:1992PNAS…89.1661K. doi:10.1073/pnas.89.5.1661. PMC 48512. PMID 1542658.
- Ozçelik T, Rosenthal A, Francke U (1991). “Chromosomal mapping of brain-derived neurotrophic factor and neurotrophin-3 genes in man and mouse”. Genomics. 10 (3): 569–75. doi:10.1016/0888-7543(91)90437-J. PMID 1889807.
- Hallböök F, Ibáñez CF, Persson H (1991). “Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary”. Neuron. 6 (5): 845–58. doi:10.1016/0896-6273(91)90180-8. PMID 2025430. S2CID 17772282.
- Jones KR, Reichardt LF (1990). “Molecular cloning of a human gene that is a member of the nerve growth factor family”. Proc. Natl. Acad. Sci. U.S.A. 87 (20): 8060–4. Bibcode:1990PNAS…87.8060J. doi:10.1073/pnas.87.20.8060. PMC 54892. PMID 2236018.
- Rosenthal A, Goeddel DV, Nguyen T, et al. (1990). “Primary structure and biological activity of a novel human neurotrophic factor”. Neuron. 4 (5): 767–73. doi:10.1016/0896-6273(90)90203-R. PMID 2344409. S2CID 30148948.
- Kaisho Y, Yoshimura K, Nakahama K (1990). “Cloning and expression of a cDNA encoding a novel human neurotrophic factor”. FEBS Lett. 266 (1–2): 187–91. doi:10.1016/0014-5793(90)81536-W. PMID 2365067. S2CID 7645464.
- Ernfors P, Lee KF, Kucera J, Jaenisch R (1994). “Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents”. Cell. 77 (4): 503–12. doi:10.1016/0092-8674(94)90213-5. PMID 7514502. S2CID 9072110.
- Robinson RC, Radziejewski C, Stuart DI, Jones EY (1995). “Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer”. Biochemistry. 34 (13): 4139–46. doi:10.1021/bi00013a001. PMID 7703225.
- Hattori M, Nanko S (1995). “Association of neurotrophin-3 gene variant with severe forms of schizophrenia”. Biochem. Biophys. Res. Commun. 209 (2): 513–8. doi:10.1006/bbrc.1995.1531. PMID 7733919.
- Tessarollo L, Vogel KS, Palko ME, et al. (1995). “Targeted mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons”. Proc. Natl. Acad. Sci. U.S.A. 91 (25): 11844–8. Bibcode:1994PNAS…9111844T. doi:10.1073/pnas.91.25.11844. PMC 45332. PMID 7991545.
- Rydén M, Ibáñez CF (1996). “Binding of neurotrophin-3 to p75LNGFR, TrkA, and TrkB mediated by a single functional epitope distinct from that recognized by trkC”. J. Biol. Chem. 271 (10): 5623–7. doi:10.1074/jbc.271.10.5623. PMID 8621424.
- Hui JO, Le J, Katta V, et al. (1996). “Human neurotrophin-3: a one-step peptide mapping method and complete disulfide characterization of the recombinant protein”. J. Protein Chem. 15 (4): 351–8. doi:10.1007/BF01886861. PMID 8819011. S2CID 34957071.
- Donovan MJ, Hahn R, Tessarollo L, Hempstead BL (1996). “Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development”. Nat. Genet. 14 (2): 210–3. doi:10.1038/ng1096-210. PMID 8841198. S2CID 9259115.
- Arinami T, Takekoshi K, Itokawa M, et al. (1996). “Failure to find associations of the CA repeat polymorphism in the first intron and the Gly-63/Glu-63 polymorphism of the neurotrophin-3 gene with schizophrenia”. Psychiatr. Genet. 6 (1): 13–5. doi:10.1097/00041444-199621000-00003. PMID 8925252. S2CID 42610869.
- Urfer R, Tsoulfas P, O’Connell L, et al. (1998). “High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors”. J. Biol. Chem. 273 (10): 5829–40. doi:10.1074/jbc.273.10.5829. PMID 9488719.
- Suenaga M, Ohmae H, Tsuji S, et al. (1998). “Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation”. Biotechnol. Appl. Biochem. 28 (2): 119–24. doi:10.1111/j.1470-8744.1998.tb00521.x. PMID 9756741. S2CID 45466609.
- Hochhaus F, Koehne P, Schäper C, et al. (2003). “Elevated nerve growth factor and neurotrophin-3 levels in cerebrospinal fluid of children with hydrocephalus”. BMC Pediatrics. 1: 2. doi:10.1186/1471-2431-1-2. PMC 57003. PMID 11580868.
- Kobayashi H, Gleich GJ, Butterfield JH, Kita H (2002). “Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli”. Blood. 99 (6): 2214–20. doi:10.1182/blood.V99.6.2214. PMID 11877300.
- Hattori M, Kunugi H, Akahane A, et al. (2002). “Novel polymorphisms in the promoter region of the neurotrophin-3 gene and their associations with schizophrenia”. Am. J. Med. Genet. 114 (3): 304–9. doi:10.1002/ajmg.10248. PMID 11920853.
Further reading (Neurotrophin-4)
- Childs AJ, Bayne RA, Murray AA, Martins Da Silva SJ, Collins CS, Spears N, Anderson RA (April 2010). “Differential expression and regulation by activin of the neurotrophins BDNF and NT4 during human and mouse ovarian development”. Developmental Dynamics. 239 (4): 1211–1219. doi:10.1002/dvdy.22252. PMC 3410523. PMID 20175187.
- Vithana EN, Nongpiur ME, Venkataraman D, Chan SH, Mavinahalli J, Aung T (August 2010). “Identification of a novel mutation in the NTF4 gene that causes primary open-angle glaucoma in a Chinese population”. Molecular Vision. 16: 1640–1645. PMC 2927376. PMID 20806036.
- Truzzi F, Marconi A, Lotti R, Dallaglio K, French LE, Hempstead BL, Pincelli C (August 2008). “Neurotrophins and their receptors stimulate melanoma cell proliferation and migration”. The Journal of Investigative Dermatology. 128 (8): 2031–2040. doi:10.1038/jid.2008.21. PMID 18305571.
- Harel S, Jin S, Fisch B, Feldberg D, Krissi H, Felz C, et al. (June 2006). “Tyrosine kinase B receptor and its activated neurotrophins in ovaries from human fetuses and adults”. Molecular Human Reproduction. 12 (6): 357–365. doi:10.1093/molehr/gal033. PMID 16648150.
- Ribasés M, Hervás A, Ramos-Quiroga JA, Bosch R, Bielsa A, Gastaminza X, et al. (May 2008). “Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder”. Biological Psychiatry. 63 (10): 935–945. doi:10.1016/j.biopsych.2007.11.004. PMID 18179783. S2CID 15820930.
- Chen ZY, Ieraci A, Teng H, Dall H, Meng CX, Herrera DG, et al. (June 2005). “Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway”. The Journal of Neuroscience. 25 (26): 6156–6166. doi:10.1523/JNEUROSCI.1017-05.2005. PMC 1201519. PMID 15987945.
- Pasutto F, Matsumoto T, Mardin CY, Sticht H, Brandstätter JH, Michels-Rautenstrauss K, et al. (October 2009). “Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma”. American Journal of Human Genetics. 85 (4): 447–456. doi:10.1016/j.ajhg.2009.08.016. PMC 2756554. PMID 19765683.
- Ibáñez CF (July 1996). “Neurotrophin-4: the odd one out in the neurotrophin family”. Neurochemical Research. 21 (7): 787–793. doi:10.1007/BF02532301. PMID 8873083. S2CID 10824679.
- Nalbandian A, Pang AL, Rennert OM, Chan WY, Ravindranath N, Djakiew D (October 2005). “A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression”. Differentiation; Research in Biological Diversity. 73 (8): 385–396. doi:10.1111/j.1432-0436.2005.00040.x. PMID 16316409.
- Liu Y, Liu W, Crooks K, Schmidt S, Allingham RR, Hauser MA (March 2010). “No evidence of association of heterozygous NTF4 mutations in patients with primary open-angle glaucoma”. American Journal of Human Genetics. 86 (3): 498–9, author reply 500. doi:10.1016/j.ajhg.2009.11.018. PMC 2833375. PMID 20215012.
- Götz R, Schartl M (May 1994). “The conservation of neurotrophic factors during vertebrate evolution” (PDF). Comparative Biochemistry and Physiology. Pharmacology, Toxicology and Endocrinology. 108 (1): 1–10. doi:10.1016/1367-8280(94)90082-5. PMID 8061955.
- Gratacòs M, Escaramís G, Bustamante M, Saus E, Agüera Z, Bayés M, et al. (October 2010). “Role of the neurotrophin network in eating disorders’ subphenotypes: body mass index and age at onset of the disease”. Journal of Psychiatric Research. 44 (13): 834–840. doi:10.1016/j.jpsychires.2010.01.009. PMID 20219210.
- Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C, et al. (June 2009). “Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome”. Autism Research. 2 (3): 157–177. doi:10.1002/aur.80. PMID 19598235. S2CID 18239947.
- Mizuno N, Shiba H, Inui T, Takeda K, Kajiya M, Hasegawa N, et al. (November 2008). “Effect of neurotrophin-4/5 on bone/cementum-related protein expressions and DNA synthesis in cultures of human periodontal ligament cells”. Journal of Periodontology. 79 (11): 2182–2189. doi:10.1902/jop.2008.070402. PMID 18980528.
- Rao KN, Kaur I, Parikh RS, Mandal AK, Chandrasekhar G, Thomas R, Chakrabarti S (October 2010). “Variations in NTF4, VAV2, and VAV3 genes are not involved with primary open-angle and primary angle-closure glaucomas in an indian population”. Investigative Ophthalmology & Visual Science. 51 (10): 4937–4941. doi:10.1167/iovs.10-5553. PMID 20463313.
- Gratacòs M, Costas J, de Cid R, Bayés M, González JR, Baca-García E, et al. (September 2009). “Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment”. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 150B (6): 808–816. doi:10.1002/ajmg.b.30902. PMID 19086053. S2CID 44524739.
- Mercader JM, Saus E, Agüera Z, Bayés M, Boni C, Carreras A, et al. (May 2008). “Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders”. Human Molecular Genetics. 17 (9): 1234–1244. doi:10.1093/hmg/ddn013. hdl:10230/16493. PMID 18203754.
- Walz JC, Magalhães PV, Giglio LM, Cunha AB, Stertz L, Fries GR, et al. (April 2009). “Increased serum neurotrophin-4/5 levels in bipolar disorder”. Journal of Psychiatric Research. 43 (7): 721–723. doi:10.1016/j.jpsychires.2008.10.005. PMID 19081579. S2CID 7379020.
- Prakash YS, Iyanoye A, Ay B, Mantilla CB, Pabelick CM (September 2006). “Neurotrophin effects on intracellular Ca2+ and force in airway smooth muscle”. American Journal of Physiology. Lung Cellular and Molecular Physiology. 291 (3): L447–L456. doi:10.1152/ajplung.00501.2005. PMID 16648236.
External links
- neurotrophin+4 at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- neurotrophin+5 at the U.S. National Library of Medicine Medical Subject Headings (MeSH)